NCT01526278View on ClinicalTrials.gov

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2012

Conditions
Osteoporosis
Interventions
DRUG

Maxmarvil®

Drug : Maxmarvil® 1tablet one time in clinical trial, PO medication

Trial Locations (1)

Unknown

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Yuyu Pharma, Inc.

INDUSTRY

NCT01526278 - Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter